A

Alkermes plc
D

ALKS

35.260
USD
-0.24
(-0.68%)
مغلق
حجم التداول
32,806
الربح لكل سهم
1
العائد الربحي
-
P/E
16
حجم السوق
5,733,772,002
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AAL
    -0.635
    (-4.00%)
    15.225 USD
    A
    ALGT
    -4.300
    (-5.00%)
    81.640 USD
    A
    ALK
    -5.140
    (-6.82%)
    70.210 USD
    DAL
    DAL
    -3.770
    (-5.91%)
    59.980 USD
    J
    JBLU
    -0.23500
    (-3.24%)
    7.01500 USD
    L
    LUV
    -0.805
    (-2.63%)
    29.800 USD
    U
    UAL
    -6.540
    (-6.38%)
    95.930 USD
    المزيد
الأخبار
المقالات

العنوان: Alkermes plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.